bioMérieux S.A. (VIE:BIM)

bioMérieux Statistics

Total Valuation

bioMérieux has a market cap or net worth of EUR 11.25 billion. The enterprise value is 11.14 billion.

Market Cap	11.25B
Enterprise Value	11.14B

Important Dates

The last earnings date was Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	Jun 9, 2025

Share Statistics

Current Share Class	118.07M
Shares Outstanding	n/a
Shares Change (YoY)	+0.23%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	18.19%
Float	44.73M

Valuation Ratios

The trailing PE ratio is 28.29 and the forward PE ratio is 19.95.

PE Ratio	28.29
Forward PE	19.95
PS Ratio	2.76
PB Ratio	2.74
P/TBV Ratio	3.78
P/FCF Ratio	24.83
P/OCF Ratio	14.27
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.15, with an EV/FCF ratio of 24.59.

EV / Earnings	28.03
EV / Sales	2.74
EV / EBITDA	11.15
EV / EBIT	19.85
EV / FCF	24.59

Financial Position

The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.11.

Current Ratio	2.39
Quick Ratio	1.48
Debt / Equity	0.11
Debt / EBITDA	0.46
Debt / FCF	1.02
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 9.54% and return on invested capital (ROIC) is 10.60%.

Return on Equity (ROE)	9.54%
Return on Assets (ROA)	6.18%
Return on Invested Capital (ROIC)	10.60%
Return on Capital Employed (ROCE)	12.44%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	281,628
Profits Per Employee	27,507
Employee Count	14,451
Asset Turnover	0.72
Inventory Turnover	1.76

Taxes

In the past 12 months, bioMérieux has paid 128.80 million in taxes.

Income Tax	128.80M
Effective Tax Rate	24.50%

Stock Price Statistics

The stock price has decreased by -17.62% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-17.62%
50-Day Moving Average	101.34
200-Day Moving Average	112.22
Relative Strength Index (RSI)	42.89
Average Volume (20 Days)	13

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, bioMérieux had revenue of EUR 4.07 billion and earned 397.50 million in profits. Earnings per share was 3.34.

Revenue	4.07B
Gross Profit	2.31B
Operating Income	561.20M
Pretax Income	525.70M
Net Income	397.50M
EBITDA	999.60M
EBIT	561.20M
Earnings Per Share (EPS)	3.34

Balance Sheet

The company has 569.80 million in cash and 461.40 million in debt, with a net cash position of 108.40 million.

Cash & Cash Equivalents	569.80M
Total Debt	461.40M
Net Cash	108.40M
Net Cash Per Share	n/a
Equity (Book Value)	4.11B
Book Value Per Share	34.90
Working Capital	1.48B

Cash Flow

In the last 12 months, operating cash flow was 788.30 million and capital expenditures -335.30 million, giving a free cash flow of 453.00 million.

Operating Cash Flow	788.30M
Capital Expenditures	-335.30M
Free Cash Flow	453.00M
FCF Per Share	n/a

Margins

Gross margin is 56.73%, with operating and profit margins of 13.79% and 9.77%.

Gross Margin	56.73%
Operating Margin	13.79%
Pretax Margin	12.92%
Profit Margin	9.77%
EBITDA Margin	24.56%
EBIT Margin	13.79%
FCF Margin	11.13%

Dividends & Yields

This stock pays an annual dividend of 0.90, which amounts to a dividend yield of 0.91%.

Dividend Per Share	0.90
Dividend Yield	0.91%
Dividend Growth (YoY)	5.88%
Years of Dividend Growth	1
Payout Ratio	26.69%
Buyback Yield	-0.23%
Shareholder Yield	0.68%
Earnings Yield	3.53%
FCF Yield	4.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

bioMérieux has an Altman Z-Score of 7.03 and a Piotroski F-Score of 6.

Altman Z-Score	7.03
Piotroski F-Score	6